About Lanthio Pharma
Lanthio Pharma is a company based in Groningen (Netherlands) founded in 2010 was acquired by MorphoSys in May 2015. Lanthio Pharma has raised $6.27 million across 3 funding rounds from investors including MorphoSys, Rijksdienst voor Ondernemend Nederland and BioGeneration Ventures.
- Headquarter Groningen, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lanthio Pharma
Lanthio Pharma has successfully raised a total of $6.27M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4.93 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lanthio Pharma
Lanthio Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include MorphoSys, Rijksdienst voor Ondernemend Nederland and BioGeneration Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science focused VC firm investing in startups in Europe
|
Locked | Locked | Locked | |
|
AI, deeptech, and healthcare tech companies are funded by Inkef.
|
Locked | Locked | Locked | |
|
Provider of subsidies and financial support for businesses
|
Locked | Locked | Locked |
Investor details for Lanthio Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lanthio Pharma
Investment portfolio details for Lanthio Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lanthio Pharma
Detailed financials for Lanthio Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lanthio Pharma Comparisons
Peer comparison for Lanthio Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lanthio Pharma
Detailed competitors of Lanthio Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lanthio Pharma
Complete news archive for Lanthio Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lanthio Pharma
Lanthio Pharma was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Lanthio Pharma is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.
Lanthio Pharma is a funded company, having raised a total of $6.27M across 3 funding rounds to date.
Lanthio Pharma is committed to developing and commercializing therapeutic peptides against difficult to target receptors (e.g. GPCRs). With its proprietary LanthioPep technology, the company is generating peptide drugs that are markedly enhanced for stability and selectivity. Company is building a growing pipeline of stabilized, receptor specific lanthipeptides with the potential for treatment of fibrosis, heart failure and multiple sclerosis. Pipeline includes LP2 for diabetic nephropathy, lanthi-apelin for heart failure, lanthi-galani for multiple sclerosis and pancyte (indication is confidential). company was acquired by morphosys in 2015.
Lanthio Pharma has 4 investors. Key investors include MorphoSys, Rijksdienst voor Ondernemend Nederland, BioGeneration Ventures, and Inkef.